Inventor
DONALD JOHNS
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes46%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms15%
PatentTitleYear
12,215,387Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment202512,201,612Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use202511,878,001Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use202411,369,603Use of a H3R inverse agonist for the treatment of shift work disorder202211,359,241Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment202211,311,525Use of alpha 7 nicotinic acetylcholine receptor agonists2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to NOVARTIS AG (6)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 6 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |